
Nizal S. Chandrakumar
Examiner (ID: 111, Phone: (571)272-6202 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625 |
| Total Applications | 2819 |
| Issued Applications | 1922 |
| Pending Applications | 209 |
| Abandoned Applications | 730 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16008853
[patent_doc_number] => 20200179269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => VAPORIZABLE COMPOSITIONS COMPRISING CANNABINOL
[patent_app_type] => utility
[patent_app_number] => 16/495468
[patent_app_country] => US
[patent_app_date] => 2018-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495468 | VAPORIZABLE COMPOSITIONS COMPRISING CANNABINOL | Mar 19, 2018 | Abandoned |
Array
(
[id] => 18664838
[patent_doc_number] => 11771703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Targeted epigenetic therapy against distal regulatory element of TGFb2 expression
[patent_app_type] => utility
[patent_app_number] => 16/495098
[patent_app_country] => US
[patent_app_date] => 2018-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 22
[patent_no_of_words] => 22240
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495098
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/495098 | Targeted epigenetic therapy against distal regulatory element of TGFb2 expression | Mar 15, 2018 | Issued |
Array
(
[id] => 15454321
[patent_doc_number] => 20200039985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 16/496073
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 649
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496073 | Modulators of the sigma-2 receptor and their method of use | Mar 14, 2018 | Issued |
Array
(
[id] => 15253981
[patent_doc_number] => 20190375724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => PROCESS FOR PREPARING A CYCLIC DIESTER OR A CYCLIC DIAMIDE BY REACTING A HYDROXYCARBOXYLIC ACID OR AMIDE WITH AN ACIDIC BEA-TYPE (H-BETA POLYMORPH A) ZEOLITE
[patent_app_type] => utility
[patent_app_number] => 16/485291
[patent_app_country] => US
[patent_app_date] => 2018-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 265
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485291
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485291 | PROCESS FOR PREPARING A CYCLIC DIESTER OR A CYCLIC DIAMIDE BY REACTING A HYDROXYCARBOXYLIC ACID OR AMIDE WITH AN ACIDIC BEA-TYPE (H-BETA POLYMORPH A) ZEOLITE | Mar 13, 2018 | Abandoned |
Array
(
[id] => 15828699
[patent_doc_number] => 20200129631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => PYRROLOQUINOLIN COMPOUNDS AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/493690
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16293
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16493690
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/493690 | Pyrroloquinolin compounds and methods of using same | Mar 12, 2018 | Issued |
Array
(
[id] => 13297419
[patent_doc_number] => 20180200246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => CRYSTALLINE FORMS OF AN 8-AZABICYCLO[3.2.1]OCTANE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 15/919678
[patent_app_country] => US
[patent_app_date] => 2018-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14491
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15919678
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/919678 | Crystalline forms of an 8-azabicyclo[3.2.1]octane compound | Mar 12, 2018 | Issued |
Array
(
[id] => 17517120
[patent_doc_number] => 11296281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Materials for organic electroluminescent devices
[patent_app_type] => utility
[patent_app_number] => 16/492820
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10845
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 781
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492820
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492820 | Materials for organic electroluminescent devices | Mar 11, 2018 | Issued |
Array
(
[id] => 15574023
[patent_doc_number] => 10577378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => EIF4A-inhibiting compounds and methods related thereto
[patent_app_type] => utility
[patent_app_number] => 15/917973
[patent_app_country] => US
[patent_app_date] => 2018-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 148863
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 347
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15917973
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/917973 | EIF4A-inhibiting compounds and methods related thereto | Mar 11, 2018 | Issued |
| 15/916015 | Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof | Mar 7, 2018 | Abandoned |
Array
(
[id] => 14836031
[patent_doc_number] => 20190276416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHOD FOR PREPARING NOTA DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 15/912734
[patent_app_country] => US
[patent_app_date] => 2018-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2954
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15912734
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/912734 | METHOD FOR PREPARING NOTA DERIVATIVE | Mar 5, 2018 | Abandoned |
Array
(
[id] => 15102101
[patent_doc_number] => 10472350
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-12
[patent_title] => Soluble guanylate cyclase activators and their use
[patent_app_type] => utility
[patent_app_number] => 15/911797
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24064
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15911797
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/911797 | Soluble guanylate cyclase activators and their use | Mar 4, 2018 | Issued |
Array
(
[id] => 13479115
[patent_doc_number] => 20180291100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => CROSS-LINKERS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 15/911571
[patent_app_country] => US
[patent_app_date] => 2018-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24109
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15911571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/911571 | Cross-linkers and their uses | Mar 4, 2018 | Issued |
Array
(
[id] => 16807733
[patent_doc_number] => 20210130286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION
[patent_app_type] => utility
[patent_app_number] => 16/491594
[patent_app_country] => US
[patent_app_date] => 2018-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9232
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491594
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/491594 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | Mar 3, 2018 | Abandoned |
Array
(
[id] => 15590147
[patent_doc_number] => 20200071608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => PHOSPHINE PRECURSOR FOR PREPARING QUANTUM DOT AND QUANTUM DOT PREPARED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 16/489412
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489412
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489412 | Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom | Mar 1, 2018 | Issued |
Array
(
[id] => 17466697
[patent_doc_number] => 11273154
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Azole compounds as ubiquitin-specific protease USP7 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/490722
[patent_app_country] => US
[patent_app_date] => 2018-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 12170
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490722
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/490722 | Azole compounds as ubiquitin-specific protease USP7 inhibitors | Mar 1, 2018 | Issued |
Array
(
[id] => 17193103
[patent_doc_number] => 11161844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Cyclic substituted imidazo[4,5-c]quinoline derivatives
[patent_app_type] => utility
[patent_app_number] => 16/492554
[patent_app_country] => US
[patent_app_date] => 2018-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34254
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492554
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/492554 | Cyclic substituted imidazo[4,5-c]quinoline derivatives | Feb 28, 2018 | Issued |
Array
(
[id] => 13383411
[patent_doc_number] => 20180243247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => DRUG COMBINATIONS FOR CEREBROVASCULAR DISEASE
[patent_app_type] => utility
[patent_app_number] => 15/907239
[patent_app_country] => US
[patent_app_date] => 2018-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11020
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15907239
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/907239 | DRUG COMBINATIONS FOR CEREBROVASCULAR DISEASE | Feb 26, 2018 | Abandoned |
Array
(
[id] => 15527055
[patent_doc_number] => 20200055833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => HYDROPHOBIC COMPOUNDS FOR OPTICALLY ACTIVE DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/485844
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 574
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485844
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485844 | Hydrophobic compounds for optically active devices | Feb 13, 2018 | Issued |
Array
(
[id] => 18504592
[patent_doc_number] => 11702396
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Hydrophobic compounds for optically active devices
[patent_app_type] => utility
[patent_app_number] => 16/486349
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13904
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486349 | Hydrophobic compounds for optically active devices | Feb 13, 2018 | Issued |
Array
(
[id] => 16842827
[patent_doc_number] => 11014900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-25
[patent_title] => Hydrophilic compounds for optically active devices
[patent_app_type] => utility
[patent_app_number] => 16/486340
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15263
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 478
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486340
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486340 | Hydrophilic compounds for optically active devices | Feb 13, 2018 | Issued |